Venous Thromboembolism in Myelodysplastic Syndrome Patients Receiving Lenalidomide: Results from Postmarketing Surveillance and Data Mining Techniques

Author： Yang Xionghu  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.29, Iss.3, 2009-02, pp. : 161-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Real-life Safety and Efficacy of Vardenafil: an International Post-marketing Surveillance Study – Results from 29 358 German Patients

By van Ahlen H   Zumbé J   Stauch K   Landen H  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 337-348

Field House Publishing

Access to resources Recommend Favorite

Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma

By Shah Sachin R.  

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1869-1881

Adis International

Access to resources Recommend Favorite

Safety of Zafirlukast: Results of a Postmarketing Surveillance Study on 7976 Patients in England

By Twaites Beverley R.   Wilton Lynda V.   Shakir Saad A.W.  

Drug Safety, Vol. 30, Iss. 5, 2007-01 ,pp. : 419-429

Adis International

Access to resources Recommend Favorite

The Pharmacovigilance of Pantoprazole: The Results of Postmarketing Surveillance on 11 541 Patients in England

By Wilton L.V.   Key C.   Shakir S.A.W.  

Drug Safety, Vol. 26, Iss. 2, 2003-01 ,pp. : 121-132

Adis International

Access to resources Recommend Favorite

Valsartan Alone and in Combination with Hydrochlorothiazide in General Practice: Results from Two Postmarketing Surveillance Studies Involving 54 928 Patients with Essential Hypertension

By Scholze J.  

Clinical Drug Investigation, Vol. 20, Iss. 1, 2000-07 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite